Results 271 to 280 of about 214,937 (381)

High Salt Intake Is Associated with Atrophic Gastritis with Intestinal Metaplasia

open access: yesCancer Epidemiology, Biomarkers and Prevention, 2017
J. Song   +6 more
semanticscholar   +1 more source

Autoimmune gastritis: clinical and histological study in a Peruvian population. [PDF]

open access: yesBMC Gastroenterol
Arevalo F   +8 more
europepmc   +1 more source

Anti-Helicobacter pyloriactivity and inhibition of gastritis byAllium hookeriextract

open access: diamond, 2018
Hyun-A Lee   +4 more
openalex   +1 more source

S3 Guideline for the treatment of psoriasis vulgaris, adapted from EuroGuiDerm – part 1: Treatment recommendations and monitoring

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 1, Page 122-137, January 2026.
Summary This first part of the updated German S3 guideline on the treatment of psoriasis vulgaris covers the sections on treatment recommendations, treatment goals, and monitoring of therapies. The recommendations are based on the current Cochrane network meta‐analysis, the results of which are also summarized.
Alexander Nast   +25 more
wiley   +1 more source

S3‐Leitlinie zur Therapie der Psoriasis vulgaris, adaptiert von EuroGuiDerm – Teil 1: Therapieempfehlungen und Monitoring

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 1, Page 122-139, January 2026.
Zusammenfassung Der vorliegende Teil 1 der Aktualisierung der S3‐Leitlinie zur Therapie der Psoriasis vulgaris umfasst die Abschnitte „Therapieempfehlungen“, „Therapieziele“ sowie die „Monitoringempfehlungen“ zu den Therapien. Die Grundlage bildet die aktuelle Cochrane‐Netzwerkmetaanalyse, deren Ergebnisse ebenfalls dargestellt werden.
Alexander Nast   +25 more
wiley   +1 more source

Cellular and humoral immune responses in Campylobacter pylori‐associated chronic gastritis

open access: hybrid, 1989
Javed Iqbal Kazi   +6 more
openalex   +1 more source

Relative efficacy of GLP‐1 and GLP‐1/GIP receptor agonists in the prevention of alcohol‐use disorders using a target trial emulation approach

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 137-150, January 2026.
Abstract Aims There is growing evidence that the GLP‐1 system is implicated in alcohol and other substance use disorders, and that GLP‐1‐based therapies may have therapeutic relevance in alcohol use disorder (AUD). We aimed to determine the impact of GLP‐1 based therapies on incident AUDs in a real‐world setting in patients with T2D.
Alex E. Henney   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy